MedPath
NMPA Approval

Compound Paracetamol and Diphenhydramine Hydrochloride Tablets

国药准字H21023182

March 16, 2021

国药准字H21023182

Drug Information

复方氨酚苯海拉明片

片剂

复方

化学药品

March 16, 2021

Company Information

Applicant Company

辽宁省沈阳市沈北新区虎石台镇建设北三路

Manufacturing Company

沈阳市沈北新区金星街55号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.